Results of Gemaza therapy of hemophthalmia in patients with diabetic retinopathy

Aim. To evaluate efficiency of Gemaza used to treat hemophthalmia of different severity and localization. Materials and methods. Gemaza (5000 IU) was admnistered parabulbarly to 75 patients (78 eyes) with diabetes mellitus (DM) after dilution in0.5 ml of 0.9% sodium chloride solution. Each patient...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Nargiza Mirshavkatovna Normatova
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2010
Materias:	diabetic retinopathy hemophthalmia gemaza Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/622a2c390f2f4110b22354ebd8319b32
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:622a2c390f2f4110b22354ebd8319b32
record_format	dspace
spelling	oai:doaj.org-article:622a2c390f2f4110b22354ebd8319b322021-11-14T09:00:15ZResults of Gemaza therapy of hemophthalmia in patients with diabetic retinopathy2072-03512072-037810.14341/2072-0351-5683https://doaj.org/article/622a2c390f2f4110b22354ebd8319b322010-06-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/5683https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Aim. To evaluate efficiency of Gemaza used to treat hemophthalmia of different severity and localization. Materials and methods. Gemaza (5000 IU) was admnistered parabulbarly to 75 patients (78 eyes) with diabetes mellitus (DM) after dilution in0.5 ml of 0.9% sodium chloride solution. Each patient received 10 daily injections during baseline hypoglycemic therapy. Control group was comprisedof 20 patients (20 eyes) with hemophthalmia, treated by traditional drug therapy (emoxipin, dicinon, ascorutin, actovegin). Results. Gemaza proved a highly efficient agent showing hemoresorptive and fibrinolytic activities; it improved visual acuity in 51.3% of the patientsfrom day 5 after the onset of therapy. Conclusion. It is recommended to administer Gemaza soon after hemorrhage, prior to the development of proliferative processes in the vitreous bodyand retina.Nargiza Mirshavkatovna NormatovaEndocrinology Research Centrearticlediabetic retinopathyhemophthalmiagemazaNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 13, Iss 2, Pp 97-99 (2010)
institution	DOAJ
collection	DOAJ
language	EN RU
topic	diabetic retinopathy hemophthalmia gemaza Nutritional diseases. Deficiency diseases RC620-627
spellingShingle	diabetic retinopathy hemophthalmia gemaza Nutritional diseases. Deficiency diseases RC620-627 Nargiza Mirshavkatovna Normatova Results of Gemaza therapy of hemophthalmia in patients with diabetic retinopathy
description	Aim. To evaluate efficiency of Gemaza used to treat hemophthalmia of different severity and localization. Materials and methods. Gemaza (5000 IU) was admnistered parabulbarly to 75 patients (78 eyes) with diabetes mellitus (DM) after dilution in0.5 ml of 0.9% sodium chloride solution. Each patient received 10 daily injections during baseline hypoglycemic therapy. Control group was comprisedof 20 patients (20 eyes) with hemophthalmia, treated by traditional drug therapy (emoxipin, dicinon, ascorutin, actovegin). Results. Gemaza proved a highly efficient agent showing hemoresorptive and fibrinolytic activities; it improved visual acuity in 51.3% of the patientsfrom day 5 after the onset of therapy. Conclusion. It is recommended to administer Gemaza soon after hemorrhage, prior to the development of proliferative processes in the vitreous bodyand retina.
format	article
author	Nargiza Mirshavkatovna Normatova
author_facet	Nargiza Mirshavkatovna Normatova
author_sort	Nargiza Mirshavkatovna Normatova
title	Results of Gemaza therapy of hemophthalmia in patients with diabetic retinopathy
title_short	Results of Gemaza therapy of hemophthalmia in patients with diabetic retinopathy
title_full	Results of Gemaza therapy of hemophthalmia in patients with diabetic retinopathy
title_fullStr	Results of Gemaza therapy of hemophthalmia in patients with diabetic retinopathy
title_full_unstemmed	Results of Gemaza therapy of hemophthalmia in patients with diabetic retinopathy
title_sort	results of gemaza therapy of hemophthalmia in patients with diabetic retinopathy
publisher	Endocrinology Research Centre
publishDate	2010
url	https://doaj.org/article/622a2c390f2f4110b22354ebd8319b32
work_keys_str_mv	AT nargizamirshavkatovnanormatova resultsofgemazatherapyofhemophthalmiainpatientswithdiabeticretinopathy
_version_	1718429654271918080

Results of Gemaza therapy of hemophthalmia in patients with diabetic retinopathy

Ejemplares similares